Health: licensing; references to licenses for certain substance use disorder services programs in the patient’s right to independent review act; modify to include those exempt from licensure. Amends sec. 3 of 2000 PA 251 (MCL 550.1903). TIE BAR WITH: HB 5729'26
HB 5736 amends the Patient’s Right to Independent Review Act by revising the act’s definitions section. The bill updates and expands several statutory definitions used in Michigan’s external review and utilization review framework, including terms such as adverse determination, health carrier, health care provider, health facility, protected health information, medical or scientific evidence, and utilization review organization. The most notable substantive change reflected in the bill title and context is that references to substance use disorder services programs are broadened to include programs that are exempt from licensure, not just those that are licensed under the Public Health Code.
Because the bill is largely definitional, it does not create a new review process or alter the basic right to independent external review. Instead, it clarifies which entities and services are covered by the act and how the review system applies to them. The bill is tied to HB 5729, meaning it would not take effect unless that companion bill becomes law. In practical terms, the measure would affect health carriers, utilization review organizations, providers, and patients seeking review of denied or modified health care services, especially in the substance use disorder treatment context.
The general sentiment around the bill appears neutral to favorable, based on its technical and clarifying nature and the absence of recorded opposition, votes, or committee debate in the provided materials. The bill reads as a cleanup and modernization measure rather than a controversial policy shift, with an emphasis on aligning statutory language with current health care and licensing structures.
The main point of potential contention is the scope of coverage for substance use disorder services programs, specifically whether exempt programs should be treated the same as licensed programs under the independent review act. More broadly, any debate would likely center on how expanded definitions affect insurer obligations, provider compliance, and patient access to external review, but no explicit opposition or competing viewpoints are included in the available record.
HB 5736 would amend section 3 of the Patient’s Right to Independent Review Act, MCL 550.1903, by revising statutory definitions that govern external review of health insurance utilization decisions. The bill would affect how Michigan law defines covered persons, health carriers, health facilities, utilization review, adverse determinations, and related terms, and it specifically expands the reference to substance use disorder services programs to include programs exempt from licensure. This would likely broaden the reach of the act to additional treatment providers and clarify insurer and review-organization responsibilities in disputes over medical necessity and coverage.
The available context suggests a generally favorable or at least noncontroversial sentiment. The bill is technical in nature, focused on definitional updates and alignment of statutory language, and there is no recorded committee testimony, vote tally, or stated opposition in the materials provided. Its tie-bar to HB 5729 also indicates it is part of a coordinated legislative package rather than an isolated policy fight.
The most notable issue is the inclusion of substance use disorder services programs that are exempt from licensure, which may raise questions about the scope of the independent review act and the obligations imposed on insurers and review organizations. Any contention would likely come from stakeholders concerned about expanded coverage or regulatory burden versus those supporting broader patient access to review for behavioral health and addiction treatment services. No specific opponents, amendments, or floor debate are provided in the record.